I have a financial interest in Poolbeg Pharma.
By Elric Langton | 27 June 2022
First time AI used to model RSV with complete longitudinal disease data
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model, announces that, further to its announcement in February 2022, β¦